FindTrial
Sign In

To test the safety of the hydration mist by PIPT on normal and sensitive skin

Dermatological Safety Evaluation of Hydrating Mist by Primary Irritation Patch Test Within 24 Hours of Apply on Healthy Adult Females of Both Normal and Sensitive Skin types

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052948
Enrollment
34
Registered
2023-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hydrating mist: Hydrating mist- Once on Day 1 Control Intervention1: Negative Control: 0.9 % Normal Saline Control Intervention2: Positive Control: SLS

Sponsors

DPKA Universal Consumer Ventures Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Voluntary healthy adult females between 18 and 65 years. 2.Having healthy skin on test area as assessed by dermatological examination. 3.For whom the investigator considers that the compliance will be correct.

Exclusion criteria

Exclusion criteria: 1.Pregnant/nursing mothers. 2.Scars, excessive terminal hair, or tattoos on the studied area. 3.Dermatological infection/ pathology on level of studied area.

Design outcomes

Primary

MeasureTime frame
1. Number of subjects that showed no significant irritation. 2. Score of less than or equal to 2 on the Draize scale. Timepoint: Day 1, Day 2, Day 3, Day 8—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactMeena Dalal

Trial Guna Pvt Ltd

drsohanshetty@yahoo.co.in8867125414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026